Magnesium supplementation and preeclampsia in low-income pregnant women - a randomized double-blind clinical trial

Carla Adriane Leal de Araújo, Larissa de Sousa Oliveira, Isabela Melo Buarque de Gusmão, Angélica Guimarães, Moranna Ribeiro, João Guilherme Bezerra Alves, Carla Adriane Leal de Araújo, Larissa de Sousa Oliveira, Isabela Melo Buarque de Gusmão, Angélica Guimarães, Moranna Ribeiro, João Guilherme Bezerra Alves

Abstract

Background: Preeclampsia is the major cause of maternal morbidity and mortality in developing countries. Magnesium sulfate is considered first-line therapy against eclampsia and magnesium deficiency in pregnancy has been associated with unfavourable perinatal outcomes. However there are doubts if magnesium supplementation during pregnancy can previne preeclampsia especially in population with high nutritional risk. This trial aims to verify the effect of oral magnesium supplmentation on preeclampsia incidence in low income pregnant women.

Methods: This randomized, double-blind, placebo-controlled trial investigated the effect of oral magnesium citrate supplementation for preeclampsia in low-income Brazilian pregnant women, i.e. annual per capita income of US$ 1025 or less. Participants were admitted to the study with gestational age between 12 and 20 weeks. Magnesium serum level was measured pre-randomization and participants with hypermagnesemia were excluded. After randomizationg participants received magnesium citrate capsule (300 mg magnesium citrate) or a daily placebo capsule, until delivery. Intent-to-treat analysis was performed.

Results: A total of 416 pregnant women were screened and 318 enrolled according to the inclusion criteria; 159 for each arm. Twenty-eight pregnant women were lost to follow-up. 55/290 (18.9%) of pregnant women developed preeclampsia; 26/143 (18.1%) in magnesium group and 29/147 (19.7%) in the control group; OR 0.90 (CI 95% 0.48-1.69), p = 0.747. No cases of eclampsia were registered.

Conclusion: Oral magnesium supplementation did not reduce preeclampsia incidence in low-income and low-risk pregnant women.

Trial registration: Registered at ClinicalTrials.gov (Identifier NCT02032186), December 19, 2013.

Keywords: Oral magnesium; Preeclampsia; Pregnancy.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Consort flowchart: Oral magnesium supplementation and preeclampsia

References

    1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–137. doi: 10.1053/j.semperi.2009.02.010.
    1. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36:56–59. doi: 10.1053/j.semperi.2011.09.011.
    1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99:547–553. doi: 10.1111/j.1471-0528.1992.tb13818.x.
    1. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. 2016;387(10022):999–1011. doi: 10.1016/S0140-6736(15)00070-7.
    1. Williams PJ, Broughton PF. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:405–417. doi: 10.1016/j.bpobgyn.2011.02.007.
    1. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:CD001059.44.
    1. Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;503:e1–12.45.
    1. Makrides M, Crosby DD, Bain E, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014;4:CD000937.46.
    1. D’Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health. 1992;19(2–3):117–131. doi: 10.1300/J013v19n02_07.
    1. Dorniak-Wall T, Grivell RM, Dekker GA, Hague W, Dodd JM. The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens. 2014;28:230–35.47. doi: 10.1038/jhh.2013.100.
    1. De-Regil LM, Palacios C, Ansary A, Kulier R, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2012;2:CD008873.
    1. Schoenaker DA, Soedamah-Muthu SS, Mishra GD. The association between dietary factors and gestational hypertension and pre-eclampsia: a systematic review and meta-analysis of observational studies. BMC Med. 2014;12:157. doi: 10.1186/s12916-014-0157-7.
    1. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes . Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. The National Academies Collection: Reports funded by National Institutes of Health. Washington: National Academies Press; 1997.
    1. Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes of hypertension and low birthweight. Nutr Health. 1988;6:69–88. doi: 10.1177/026010608800600201.
    1. Conradt A. Current concepts in the pathogenesis of gestosis with special reference to magnesium deficiency. Z Geburtshilfe Perinatol. 1984;188(2):49–58.
    1. Li S, Tian H. Oral low-dose magnesium gluconate preventing pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi. 1997;32(10):613–615.
    1. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989;161(1):115–119. doi: 10.1016/0002-9378(89)90246-9.
    1. Alves JG, de Araújo CA, Pontes IE, Guimarães AC, Ray JG. The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity. BMC Pregnancy Childbirth. 2014;14:222. doi: 10.1186/1471-2393-14-222.
    1. Araújo CAL, Lorena SB, Cavalcanti GCS, Leão GLS, Tenório GP, Alves JGB. Oral magnesium supplementation for leg cramps in pregnancy-An observational controlled trial. PLoS One. 2020;15(1):e0227497. doi: 10.1371/journal.pone.0227497.
    1. World Bank . Country and Lending Groups 2016. 2016.
    1. Bullarbo M, Mattson H, Broman AK, Ödman N, Nielsen TF. Magnesium supplementation and blood pressure in pregnancy: a double-blind randomized multicenter study. J Pregnancy. 2018;2018:4843159. doi: 10.1155/2018/4843159.
    1. Harrison V, Fawcus S, Jordaan E. Magnesium supplementation and perinatal hypoxia: outcome of a parallel group randomised trial in pregnancy. BJOG. 2007;114:994–1002.
    1. Melo B, Amorim M, Katz L, Coutinho I, Figueiroa JN. Hypertension, pregnancy and weather: is seasonality involved? Rev Assoc Med Bras. 2014;60(2):105–110. doi: 10.1590/1806-9282.60.02.006.
    1. Mayrink J, Souza RT, Feitosa FE, Rocha Filho EA, Leite DF, Vettorazzi J, Calderon IM, Sousa MH, Costa ML, Baker PN, Cecatti JG, Preterm SAMBA study group Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019;9(1):9517. doi: 10.1038/s41598-019-46011-3.
    1. Ismail Y, Ismail AA, Ismail AAA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med. 2010;48(3):323–327. doi: 10.1515/CCLM.2010.077.
    1. Dalton LM, Ní Fhloinn DM, Gaydadzhieva GT, Mazurkiewicz OM, Leeson H, Wright CP. Magnesium in pregnancy. Nutr Rev. 2016;74(9):549–557. doi: 10.1093/nutrit/nuw018.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere